2,208
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa

, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & show all
Pages 1770-1778 | Received 10 Jul 2020, Accepted 12 Oct 2020, Published online: 16 Dec 2020

References

  • Decker M, Edwards K, Bogaerts H. Combination vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM editors. Vaccines. 7th. PA (USA): Elsevier; 2018. p. 198–227.
  • Succi RC, Krauss MR, Harris DR, Machado DM, de Moraes-pinto MI, Mussi-Pinhata MM, Ruz NP, Pierre RB, Kolevic L, Joao E, et al. Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean. Pediatr Infect Dis J. 2013;32(8):845–50.
  • Ndirangu J, Barnighausen T, Tanser F, Tint K, Newell ML. Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa. Trop Med Int Health. 2009;14(11):1383–93. doi:10.1111/j.1365-3156.2009.02382.x.
  • Syed YY. DTaP-IPV-HepB-Hib vaccine (Hexyon®): an updated review of its use in primary and booster vaccination. Paediatr Drugs. 2019;21(5):397–408. doi:10.1007/s40272-019-00353-7.
  • World Health Organization. WHO prequalified vaccines. [Accessed 2020 September 17]. https://extranet.who.int/gavi/PQ_Web/
  • Paterson L. The European medicine agency’s article 58 procedure: reflections on the first approval for a vaccine. Regulatory Rapporteur. 2013;10:19–23.
  • Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. J Am Med Assoc. 2011;305(6):576–84. doi:10.1001/jama.2011.100.
  • Madhi SA, Izu A, Violari A, Cotton MF, Panchia R, Dobbels E, Sewraj P, van Niekerk N, Jean-Philippe P, Adrian PV, et al. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants. Vaccine. 2013;31(5):777–83. doi:10.1016/j.vaccine.2012.11.076.
  • Simani OE, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, Madhi SA. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014;28(4):531–41. doi:10.1097/QAD.0000000000000127.
  • Thanee C, Pancharoen C, Likitnukul S, Luangwedchakarn V, Umrod P, Phasomsap C, Apornpong T, Chuanchareon T, Butterworth O, Puthanakit T, et al. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children. Vaccine. 2011;29(35):5886–91. doi:10.1016/j.vaccine.2011.06.072.
  • Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014;176(1):11–22. doi:10.1111/cei.12251.
  • Woldesenbet SA, Kufa T, Lombard C, Manda S, Ayalew K, Cheyip M, Pure A. The 2017 national antenatal sentinel HIV survey, South Africa, national department of health. [Accessed 2020 September 17]. https://www.nicd.ac.za/wp-content/uploads/2019/07/Antenatal_survey-report_24July19.pdf
  • Madhi SA, Mitha I, Cutland C, Groome M, Santos-Lima E. Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. Pediatr Infect Dis J. 2011;30(4):e68–74. doi:10.1097/INF.0b013e31820b93d2.
  • Madhi SA, Lopez P, Zambrano B, Jordanov E, B’Chir S, Noriega F, Feroldi E. Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration. Hum Vaccin Immunother. 2019;15(3):658–68.
  • Madhi SA, Koen A, Cutland C, Groome M, Santos-Lima E. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Pediatr Infect Dis J. 2013;32:889–97.
  • South Africa National Department of Health. 2019 ART clinical guidelines for the management of HIV in adults, pregnancy, adolescents, children, infants and neonates. [Accessed 2020 September 17]. https://www.knowledgehub.org.za/elibrary/2019-art-clinical-guidelines-management-hiv-adults-pregnancy-adolescents-children-infants
  • South Africa National Department of Health. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. 2015 [Accessed 2020 September 17]. https://www.scribd.com/doc/268965647/National-Consolidated-Guidelines-for-PMTCT-and-the-Management-of-HIV-in-Children-Adolescents-and-Adults
  • Meyer JC, Khosa LA, Nhira S, Chiloane L, Sibanda M, Schönfeldt M, Burnett RJ. Childhood vaccination and the role of the pharmacist. South African Pharm J. 2018;85(4):26–39.
  • Itell HL, McGuire EP, Muresan P, Cunningham CK, McFarland EJ, Borkowsky W, Permar SR, Fouda GG. Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines. Vaccine. 2018;36(37):5600–08. doi:10.1016/j.vaccine.2018.07.048.
  • Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857–72. doi:10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E.
  • Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, Robinson P, Goga A. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013;91(1):70–74. doi:10.2471/BLT.12.106807.